Daily Precautions for Larotrectinib

Daily Precautions for Larotrectinib

Cancer treatment involves disease information, doctor appointments, prescription medications, and medical bills. Staying organized can significantly reduce stress. You can try the following methods: set up a personal health record on your computer to centrally manage all medical information; carry a small notebook and calendar with you to record questions, side effects, appointment times, and other details; keep receipts, lab reports, scans, and other documents in a folder or binder, or scan and save them on your computer. Additionally, taking your medication regularly is key to treatment efficacy. Keep VITRAKVI capsules in a visible place (e.g., by your bedside), use a pillbox to track daily doses, and use refrigerator magnets or a calendar to mark medication times. You can also set reminder alarms on your phone or ask family members or friends to help remind you. If you miss a dose, take it as soon as you remember; however, if it is less than 6 hours before your next scheduled dose, skip the missed dose and take the next dose as planned. If you encounter any difficulties, contact your doctor or pharmacist promptly.

What is TRK Fusion Cancer?

TRK fusion cancer can occur in adults and children. Tumor locations vary from person to person, but the underlying cause is the same — an NTRK gene fusion. Specifically, the NTRK gene abnormally connects or fuses with another gene, leading to the continuous production of TRK fusion proteins. These proteins send growth signals to cancer cells, driving tumor development. When an NTRK gene fusion is identified as the cause, the cancer may also be referred to as "TRK fusion cancer." Importantly, having TRK fusion cancer does not change your original cancer diagnosis (e.g., lung cancer or colorectal cancer); it simply explains the underlying cause of the cancer. The only way to find out if you have TRK fusion cancer is to undergo genomic testing.

What Can Genomic Testing Tell You?

Your cancer may or may not have already undergone genomic testing, so it is essential to proactively discuss this with your doctor. Genomic testing can reveal the molecular cause of your cancer, giving your doctor more information when deciding on treatment options. If you have been tested and found to be positive for an NTRK gene fusion, your doctor can match you with a therapy specifically designed for TRK fusion cancer, such as larotrectinib. If you and your doctor are considering potential treatments, you should actively ask whether an NTRK gene fusion is causing your cancer. Here are some questions you can ask your doctor about genomic testing: What are the different types of genomic testing? Which type is most appropriate for me? How is genomic testing different from hereditary genetic testing? How will the test results change my treatment path?